(AOF) – The Bastide group announces an acceleration in its organic growth of 6.1% in the second quarter of 2023-2024, to 137.1 million euros and the confirmation of adjusted 2023-2024 objectives. The home health specialist is therefore targeting an annual turnover of around 530 million euros, adjusted for the impact linked to the sale of Distrimed, and is maintaining its current operating margin objective at least equal to that achieved on the 2022-2023 financial year, or 8.4%. Debt reduction is the group’s priority for the 2023-2024 financial year: it continues to study possible asset sales.
In home care, turnover came to 106.2 million euros, down 1.6% based on published data and 0.6% on a like-for-like basis. The “Respiratory” activity confirms its very good momentum and records a turnover of 89.5 million euros, up 12.4% (+11.7% organically) and now represents 56% of respiratory services. home health.
The “Nutrition-Infusion-Stomatherapy” activity posted a turnover of 69.4 million euros, up 11.8 and 8.7% organically driven by the good performance of the Diabetes and Nutrition activities. Infusion.
AOF – LEARN MORE
Learn more about the Pharmacy sector
Oncology, priority of pharmaceutical giants
Sanofi’s stock market disappointment recorded at the end of October 2023 underlines the new direction for the group, which has now set oncology as its number 1 priority. Efforts in this segment, where therapies are advancing the fastest, notably involve investments in R&D which weigh on profitability. Sanofi therefore announced a drop in its earnings per share in 2024 and the abandonment of its objective of an operating margin of 32% in 2025. Merck has just unveiled a new alliance. It will pay up to $22 billion to the Japanese group Daiichi Sankyo as part of a partnership on experimental cancer treatments. While some experts estimate that the United States represents nearly half of global oncology spending (drugs and treatments), or $196 billion in 2022, Chinese spending in this area has more than doubled in five years, going from 5 to 11.8 billion dollars.